Leveraging global learnings to combat Antimicrobial Resistance (AMR)
This landmark study assessed the impact of AMR across 204 countries and territories and looked at the burden posed by 23 bacterial pathogens and 88 pathogen–drug combinations.
Although the threat of AMR has long been signalled, the resulting data from this major analysis are striking. In 2019 more than 1.2 million people, and potentially millions more, died as a direct result of antibiotic-resistant bacterial infections.
The study confirms AMR as a leading cause of death worldwide that is killing about 3,500 people every day with a burden likely to be higher than that of HIV or malaria.
AMR is a global problem and one that requires a holistic, collaborative, and coordinated approach pooling knowledge and best practice to drive innovative interventions and create new solutions.
Industry and academic collaboration is critical in this global war against a constantly evolving enemy. A comprehensive understanding of how AMR spreads within communities is the first, and arguably most crucial, step in unlocking this complex and multifaceted health challenge.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.